Total Funding
71
54
Total FundingSeed raised
Growth Score
-7 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
50148
RevOpsis Therapeutics employs the Surrobody platform to tackle vision loss and target diverse eye conditions with potential therapeutics.
- Ramanath Bhandari: Co-founder and Board Chairman, Interim CEO
- Ronil Patel: Chief Business Officer
About the Company
RevOpsis Therapeutics has directed its efforts towards addressing vision loss.
By utilizing their exclusive bispecific Surrobody platform, the company aims to target a diverse range of ocular conditions with potential therapeutic agents.
The company was founded in 2022 and is based in Springfield, Illinois, United States.
